Anas Alshawa

629 total citations
11 papers, 232 citations indexed

About

Anas Alshawa is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Anas Alshawa has authored 11 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Immunology and 2 papers in Genetics. Recurrent topics in Anas Alshawa's work include Cancer Immunotherapy and Biomarkers (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and CAR-T cell therapy research (2 papers). Anas Alshawa is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and CAR-T cell therapy research (2 papers). Anas Alshawa collaborates with scholars based in United States and Egypt. Anas Alshawa's co-authors include María E. Suarez‐Almazor, Noha Abdel‐Wahab, Aung Naing, Siqing Fu, Bettzy Stephen, Funda Meric‐Bernstam, Joud Hajjar, David S. Hong, Mingxuan Xu and Nazanin Majd and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and European Journal of Cancer.

In The Last Decade

Anas Alshawa

10 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anas Alshawa United States 6 126 63 57 48 47 11 232
Sylvain Dureau France 10 115 0.9× 32 0.5× 47 0.8× 13 0.3× 10 0.2× 19 214
Issa Mohamad Jordan 8 66 0.5× 66 1.0× 78 1.4× 22 0.5× 12 0.3× 45 243
Britt B.M. Suelmann Netherlands 7 95 0.8× 22 0.3× 44 0.8× 5 0.1× 26 0.6× 31 214
Julie Price Hiller Canada 5 227 1.8× 52 0.8× 68 1.2× 8 0.2× 7 0.1× 9 324
Kosuke Murakami Japan 9 59 0.5× 21 0.3× 17 0.3× 9 0.2× 6 0.1× 41 283
S. Cima Italy 8 51 0.4× 58 0.9× 35 0.6× 3 0.1× 21 0.4× 18 184
Weigang Xiu China 9 122 1.0× 20 0.3× 51 0.9× 5 0.1× 6 0.1× 25 200
O. Hernando Spain 8 72 0.6× 53 0.8× 63 1.1× 16 0.3× 9 0.2× 36 196
Justin A. Drake United States 12 182 1.4× 15 0.2× 130 2.3× 4 0.1× 26 0.6× 25 378
J.L. Coenen Netherlands 6 57 0.5× 27 0.4× 75 1.3× 44 0.9× 6 0.1× 17 178

Countries citing papers authored by Anas Alshawa

Since Specialization
Citations

This map shows the geographic impact of Anas Alshawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anas Alshawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anas Alshawa more than expected).

Fields of papers citing papers by Anas Alshawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anas Alshawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anas Alshawa. The network helps show where Anas Alshawa may publish in the future.

Co-authorship network of co-authors of Anas Alshawa

This figure shows the co-authorship network connecting the top 25 collaborators of Anas Alshawa. A scholar is included among the top collaborators of Anas Alshawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anas Alshawa. Anas Alshawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Smith, Heather, Melissa Mejía-Bautista, Anas Alshawa, et al.. (2025). IDH-wildtype astrocytoma with FH mutation, epigenetic similarity to IDH-mutant astrocytoma, and hypermethylation of CDKN2A arising in the brainstem. Journal of Neuropathology & Experimental Neurology. 85(4). 398–401.
2.
Gouda, Mohamed A., Bettzy Stephen, Yanyan Tian, et al.. (2024). A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma. SHILAP Revista de lepidopterología. 7(4). 247–254. 2 indexed citations
3.
Ahmed, Jibran, Bettzy Stephen, Sarina A. Piha‐Paul, et al.. (2023). Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies. Cancer. 130(3). 400–409. 11 indexed citations
4.
Stephen, Bettzy, Joud Hajjar, Shrutii Sarda, et al.. (2023). T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy. Journal for ImmunoTherapy of Cancer. 11(8). e007236–e007236. 9 indexed citations
5.
Alshawa, Anas, Alexandra P. Cadena, Bettzy Stephen, et al.. (2021). Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial. Investigational New Drugs. 39(4). 1113–1122. 4 indexed citations
6.
Majd, Nazanin, Steven G. Waguespack, Filip Jankú, et al.. (2020). Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study. Journal for ImmunoTherapy of Cancer. 8(2). e001532–e001532. 53 indexed citations
7.
Tapia, Coya, Phyu P. Aung, Sinchita Roy‐Chowdhuri, et al.. (2020). Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors. Journal for ImmunoTherapy of Cancer. 8(1). e000665–e000665. 8 indexed citations
8.
Alshawa, Anas, et al.. (2019). Strategic Improvement of Oral Antineoplastic Investigational Agents Compliance. SHILAP Revista de lepidopterología. 2(1). 5–10. 2 indexed citations
9.
Colen, Rivka R., Takeo Fujii, Mehmet Asım Bilen, et al.. (2017). Radiomics to predict immunotherapy-induced pneumonitis: proof of concept. Investigational New Drugs. 36(4). 601–607. 94 indexed citations
10.
Abdel‐Wahab, Noha, Anas Alshawa, & María E. Suarez‐Almazor. (2017). Adverse Events in Cancer Immunotherapy. Advances in experimental medicine and biology. 995. 155–174. 48 indexed citations
11.
Fujii, Takaaki, Rivka R. Colen, Mehmet Asım Bilen, et al.. (2016). Incidence of immune-related adverse events in patients who received immunotherapy and radiographic analysis to predict pneumonitis. European Journal of Cancer. 69. S95–S96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvain Dureau Breakdown of academic impact, for papers by Issa Mohamad Breakdown of academic impact, for papers by Britt B.M. Suelmann Breakdown of academic impact, for papers by Julie Price Hiller Breakdown of academic impact, for papers by Kosuke Murakami Breakdown of academic impact, for papers by S. Cima Breakdown of academic impact, for papers by Weigang Xiu Breakdown of academic impact, for papers by O. Hernando Breakdown of academic impact, for papers by Justin A. Drake Breakdown of academic impact, for papers by J.L. Coenen
Rankless by CCL
2026